Literature DB >> 27282537

Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity.

Nrupa Borkar1, Zhizhong Chen2, Lasse Saaby3, Anette Müllertz4, Anders E Håkansson5, Christian Schönbeck6, Mingshi Yang7, René Holm8, Huiling Mu9.   

Abstract

Oral delivery of apomorphine via prodrug principle may be a potential treatment for Parkinson's disease. The purpose of this study was to investigate the transport and stability of apomorphine and its esters across Caco-2 cell monolayer and their affinity towards chylomicrons. Apomorphine, monolauroyl apomorphine (MLA) and dilauroyl apomorphine (DLA) were subjected to apical to basolateral (A-B) and basolateral to apical (B-A) transport across Caco-2 cell monolayer. The stability of these compounds was also assessed by incubation at intestinal pH and physiological pH with and without Caco-2 cells. Molecular dynamics (MD) simulations were performed to understand the stability of the esters on a molecular level. The affinity of the compounds towards plasma derived chylomicrons was assessed. The A-B transport of intact DLA was about 150 times lower than the transport of apomorphine. In contrast, MLA was highly unstable in the aqueous media leading to apomorphine appearance basolaterally. MD simulations possibly explained the differences in hydrolysis susceptibilities of DLA and MLA. The affinity of apomorphine diesters towards plasma derived chylomicrons provided an understanding of their potential lymphatic transport. The intact DLA transport is not favorable; therefore, the conversion of DLA to MLA is an important step for intestinal apomorphine absorption.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apomorphine; Caco-2; Chylomicron affinity; Ester prodrug; Permeability; Stability

Mesh:

Substances:

Year:  2016        PMID: 27282537     DOI: 10.1016/j.ijpharm.2016.06.010

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Anti-Inflammatory Activity of Oxyresveratrol Tetraacetate, an Ester Prodrug of Oxyresveratrol, on Lipopolysaccharide-Stimulated RAW264.7 Macrophage Cells.

Authors:  Wuttinont Thaweesest; Visarut Buranasudja; Rianthong Phumsuay; Chawanphat Muangnoi; Opa Vajragupta; Boonchoo Sritularak; Paitoon Rashatasakhon; Pornchai Rojsitthisak
Journal:  Molecules       Date:  2022-06-18       Impact factor: 4.927

2.  Investigation Of Vitamin B12-Modified Amphiphilic Sodium Alginate Derivatives For Enhancing The Oral Delivery Efficacy Of Peptide Drugs.

Authors:  Lingli Long; Minghua Lai; Xuhong Mao; Jiahao Luo; Xin Yuan; Li-Ming Zhang; Zunfu Ke; Liqun Yang; David Yb Deng
Journal:  Int J Nanomedicine       Date:  2019-09-20

Review 3.  Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.

Authors:  Nrupa Borkar; Huiling Mu; René Holm
Journal:  Asian J Pharm Sci       Date:  2017-12-06       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.